The four-hour workshop will educate students aged seven to 13 on heart health.
The four-hour workshop will educate students aged seven to 13 on heart health.
The money will go towards the development of the new “Spark Building”, which will provide interim lab and office accommodation whilst more permanent accommodation is developed nearby.
The 2020 competition has welcomed a strong start to entry numbers since launching in September.
The Phase II trial results are “impressive” and “encouraging”.
76% of health leaders said in a survey that supporting and growing the NHS workforce should be a critical priority, ranking it highest.
The Invokana trial will be completed virtually, with no in-person clinical visits required.
Co-administered with aspirin, Brilinta is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndrome.
The funding announcement coincides with the launch of Cancer Research UK’s “Right Now” campaign, which aims to show both the realities of the disease and the positive impact research and improved treatments can have on people’s lives.
As of the approval, the treatment is expected to be available to patients in the coming weeks.
The trial is the first with an SGLT2 inhibitor investigating the treatment of heart failure in patients with reduced ejection fraction, with and without type II diabetes.
The industry body hopes that the proceeding Government will “shape one of our country’s most valuable assets: an incredible pharmaceutical industry that employs tens of thousands and invests billions in research.”
Isturisa, Mayzent and Polivy were among the recommendations.
The study team will review how current health and social care systems work.
The company has also submitted a marketing authorisation application for the drug to the European Medicines Agency.
Last night the annual awards ceremony for the Marketer of the Year, Communications Team of the Year & Sales competitions took place at the gorgeous Chelsea Harbour Hotel.